Describing the main findings of these works, we highlighted the advantages and the pitfalls of blood and CSF measurements of p-NfH and NfL, and we discuss their role as potential diagnostic and prognostic biomarkers in ALS. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.